alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE>                     5
<CURRENCY>                                                          USD
<MULTIPLIER>                                                          1
       

<S>                                                      <C>




<PERIOD-TYPE>                                                   9-mos
<FISCAL-YEAR-END>                                         DEC-31-1998
<PERIOD-START>                                            JAN-01-1998
<PERIOD-END>                                              SEP-30-1998
<EXCHANGE-RATE>                                                     1
<CASH>                                                     18,712,328
<SECURITIES>                                                        0
<RECEIVABLES>                                               8,028,787
<ALLOWANCES>                                                5,582,793
<INVENTORY>                                                 9,062,308
<CURRENT-ASSETS>                                           39,565,891
<PP&E>                                                      3,668,887
<DEPRECIATION>                                              3,441,940
<TOTAL-ASSETS>                                             44,634,503
<CURRENT-LIABILITIES>                                       6,635,505
<BONDS>                                                             0
<PREFERRED-MANDATORY>                                               0
<PREFERRED>                                                         0
<COMMON>                                                   25,190,579
<OTHER-SE>                                                 12,808,419
<TOTAL-LIABILITY-AND-EQUITY>                               44,634,503
<SALES>                                                    60,017,258
<TOTAL-REVENUES>                                           45,339,435
<CGS>                                                      34,754,944
<TOTAL-COSTS>                                              15,435,411
<OTHER-EXPENSES>                                              844,715
<LOSS-PROVISION>                                                    0
<INTEREST-EXPENSE>                                                  0
<INCOME-PRETAX>                                            (4,006,206)
<INCOME-TAX>                                               (1,482,296)
<INCOME-CONTINUING>                                        (2,523,909)
<DISCONTINUED>                                                      0
<EXTRAORDINARY>                                                     0
<CHANGES>                                                           0
<NET-INCOME>                                               (2,523,909)
<EPS-PRIMARY>                                                   (0.34)
<EPS-DILUTED>                                                   (0.34)
        

</TABLE>
EXHIBIT 10
PURCHASE ORDER
Electrosource International


The following number must appear on al related
Correspondence, shipping papers, and invoices:         Order
Serial Number:  ES1002

     Electrosource, Inc.                     P.O. DATE
     2809 Interstate 35 South                    17/06/99
     San Marcos                              OUR REF.
     Texas                                       CW/ch
     UNITED STATES OF AMERICA           TELEPHONE NO.    FAX NO.
                                        001 512 7536500    001
512 7536578

ITEM NO.  QTY.      DESCRIPTION                UNIT PRICE      TOTAL

               Please Supply & Deliver.
     1    8000 Maintenance free battery 12H85  USD$ 210.00  USD$1,680,000
               Prices Quoted Ex-Works USA in
               United States Dollars.
               Shipping Schedule:
               1 months A.R.O. 200 units
               3 months A.R.O. 800 units
               4 months A.R.O. 750 units
               5 months A.R.O. 750 units
               6 months A.R.O. 750 units
               7 months A.R.O. 1750 units
               8 months A.R.O. 1000 units
               9 months A.R.O. 2000 units
               Terms:
               1)   Payment to be within 30 days of
               Shipment.
                                        TOTAL PRICE         USD$1,680,000
                             Electrosource International Limited
                                   Electron 5, The Bilton Centre
                                   Business Park 5, Leatherhead,
                                                Surrey KT22 7 NF
                                                  United Kingdon
Authorised by:   /s/   Roger G. Musson
II 

111TH CONGRESS 

1ST SESSION S. 2694 

To suspend temporarily the duty on Hexanedioic acid, polymer with N- 

(2-aminoethyl)-1,3-propanediamine, aziridine, (chloromethyl)oxirane, 1,2- 

ethanediamine, N,N-1,2-ethanediylbis(1,3-propanediamine), formic acid 

and alpha-hydro-omega-hydroxypoly(oxy-1,2-ethanediyl). 

IN THE SENATE OF THE UNITED STATES 

NOVEMBER 2, 2009 

Mr. BURR introduced the following bill; which was read twice and referred to 

the Committee on Finance 

A BILL 

To suspend temporarily the duty on Hexanedioic acid, polymer with N-(2-aminoethyl)-1,3-propanediamine, aziridine, 

(chloromethyl)oxirane, 1,2-ethanediamine, N,N-1,2- 

ethanediylbis(1,3-propanediamine), formic acid and 

alpha-hydro-omega-hydroxypoly(oxy-1,2-ethanediyl). 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


jbell on DSKDVH8Z91PROD with BILLS
2 

•S 2694 IS

1 SECTION 1. HEXANEDIOIC ACID, POLYMER WITH N-(2- 

2 AMINOETHYL)-1,3-PROPANEDIAMINE, 

3 AZIRIDINE, (CHLOROMETHYL)OXIRANE, 1,2- 

4 ETHANEDIAMINE, N,N-1,2-ETHANEDIYLBIS(1,3- 

5 PROPANEDIAMINE), FORMIC ACID AND 

6 ALPHA-HYDRO-OMEGA-HYDROXYPOLY(OXY7 1,2-ETHANEDIYL). 

8 (a) IN GENERAL.—Subchapter II of chapter 99 of 

9 the Harmonized Tariff Schedule of the United States is 

10 amended by inserting in numerical sequence the following 

11 new heading: 

‘‘ 9902.01.00 Hexanedioic acid, polymer 

with N-(2-aminoethyl)-1,3- 

propanediamine, aziridine, 

(chloromethyl)oxirane, 1,2- 

ethanediamine, N,N-1,2- 

ethanediylbis(1,3- 

propanediamine), formic acid 

and alpha-hydro-omegahydroxypoly(oxy-1,2- 

ethanediyl) (CAS No. 

114133–44–7) (provided for 

in subheading 3911.90.90) ... Free No change No change On or before 

12/31/2011 ’’. 

12 (b) EFFECTIVE DATE.—The amendment made by 

13 subsection (a) applies to goods entered, or withdrawn from 

14 warehouse for consumption, on or after the 15th day after 

15 the date of the enactment of this Act. 

Æ 


jbell on DSKDVH8Z91PROD with BILLS
Exhibit 31.1



CERTIFICATION



I, Gary Kouletas, certify that:



1.

I have reviewed this quarterly report of Form 10-Q of Hybred International, Inc.



2.

Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report.



3.

Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report.



4.

The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:



a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, is made known to me by others within the company, particularly during the period in which this quarterly report is being prepared; and



b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements fort external purposes in accordance with generally accepted accounting principles; and



c)

Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based upon such evaluation; and



d)

Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting.



5.

The registrants other certifying officer and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent function);



a)

All significant deficiencies in the design or operation of internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and



b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls.



Date: November 9, 2009

/s/ Gary Kouletas

Gary Kouletas

President (Principal Executive Officer)
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     THIS SCHEDULE  CONTAINS SUMMARY  FINANCIAL  INFORMATION  EXTRACTED FROM THE
UNAUDITED FINANCIAL STATEMENTS OF MEDICAL TECHNOLOGY SYSTEMS, INC. FOR THE THREE
MONTHS ENDED JUNE 30, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                                       0000823560
<NAME>                 Medical Technology Systems, Inc.
<MULTIPLIER>                                      1000
<CURRENCY>                                          US

<S>                                        <C>
<PERIOD-TYPE>                                    3-MOS
<FISCAL-YEAR-END>                          Mar-31-2000
<PERIOD-START>                              Apr-1-1999
<PERIOD-END>                               Jun-30-1999
<EXCHANGE-RATE>                                   1.00
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                    2,432
<ALLOWANCES>                                      (225)
<INVENTORY>                                      2,126
<CURRENT-ASSETS>                                 4,552
<PP&E>                                           7,069
<DEPRECIATION>                                  (5,188)
<TOTAL-ASSETS>                                   7,717
<CURRENT-LIABILITIES>                            3,250
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          1
<COMMON>                                            64
<OTHER-SE>                                       8,583
<TOTAL-LIABILITY-AND-EQUITY>                     7,717
<SALES>                                          3,836
<TOTAL-REVENUES>                                 3,836
<CGS>                                            2,076
<TOTAL-COSTS>                                    3,785
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 294
<INCOME-PRETAX>                                     51
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                 51
<DISCONTINUED>                                   1,298
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,349
<EPS-BASIC>                                     0.21
<EPS-DILUTED>                                     0.21


</TABLE>
*Pursuant to 5TH CIR. R. 47.5, the Court has determined that this

opinion should not be published and is not precedent except under

the limited circumstances set forth in 5TH CIR. R. 47.5.4.

UNITED STATES COURT OF APPEALS

For the Fifth Circuit

No. 01-20014

Summary Calendar

EVEREST NATIONAL INSURANCE COMPANY,

Plaintiff-Counter Defendant-Appellee,

VERSUS

LJM SERVICES INC; ET AL,

Defendants

LJM SERVICES INC

Defendant-Counter Claimant-Appellant.

Appeal from the United States District Court

For the Southern District of Texas, Houston

(H-99-CV-3602)

July 11, 2001

Before SMITH, BENAVIDES, and DENNIS, Circuit Judges.

PER CURIAM:*

LJM Services, Inc. (“LJM”), appeals the grant of summary

judgment in favor of Everest National Insurance Company

(“Everest”). Everest had filed an action for declaratory judgment
No. 01-20014

--2–

to determine its rights with respect to workers compensation

insurance. The district court held, inter alia, that an agent who

solicited business for Everest and wrote the policies through

Everest’s master general agent lacked the apparent authority to add

LJM as an additional insured.

The grant of summary judgment is reviewed de novo, applying

the same standard as the district court. Pratt v. City of Houston,

Texas, 247 F.3d 601, 605-606 (5th Cir. 2001). 

Apparent authority in Texas is based on

estoppel. It may arise either from a

principal knowingly permitting an agent to

hold herself out as having authority or by a

principal’s actions which lack such ordinary

care as to clothe an agent with the indicia of

authority, thus leading a reasonably prudent

person to believe that the agent has the

authority she purports to exercise . . . A

prerequisite to a proper finding of apparent

authority is evidence of conduct by the

principal relied upon by the party asserting

the estoppel defense which would lead a

reasonably prudent person to believe an agent

had authority to so act.

Baptist Memorial Hospital System v. Sampson, 969 S.W.2d 945, 949
No. 01-20014

--3–

(Tex. 1998) (quoting Ames v. Great S. Bank, 672 S.W.2d 447, 450

(Tex. 1984)). “It is also the rule that apparent authority is not

available where the other contracting party has notice of the

limitations of the agent’s power.” G.D. Douglass v. Panama, Inc.,

504 S.W.2d 776, 779 (Tex. 1974). Certificates issued by the agent

specifically stated that they did not amend, extend or alter

coverage and that they were for information only and not to confer

any rights. See also Granite Constr. Co. v. Bituminous Ins. Co.,

832 S.W.2d 427, 429 (Tex.App.–Amarillo, 1992). LJM also had notice

of the agent’s limitations, see Douglass, 504 S.W.2d at 779.

Accordingly, we affirm.

AFFIRMED.
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 3401 Introduced in Senate (IS)]

111th CONGRESS
  2d Session
                                S. 3401

To provide for the use of unobligated discretionary stimulus dollars to 
   address AIDS Drug Assistance Program waiting lists and other cost 
          containment measures impacting State ADAP programs.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 24, 2010

 Mr. Burr (for himself and Mr. Coburn) introduced the following bill; 
     which was read twice and referred to the Committee on Health, 
                     Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL

 
To provide for the use of unobligated discretionary stimulus dollars to 
   address AIDS Drug Assistance Program waiting lists and other cost 
          containment measures impacting State ADAP programs.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Addressing Cost Containment Measures 
To Ensure the Sustainability and Success of ADAP Act'' or the ``ACCESS 
ADAP Act''.

SEC. 2. AIDS DRUG ASSISTANCE PROGRAMS.

    (a) Transfer.--There shall be transferred to the Secretary of 
Health and Human Services, $126,000,000 from discretionary amounts 
appropriated under the American Recovery and Reinvestment Act (Public 
Law 111-5) that remain unobligated, to be used by the Secretary in 
fiscal year 2010 to provide assistance in reducing AIDS Drug Assistance 
Program (under section 2616 of the Public Health Service Act (42 U.S.C. 
300ff-26)) waiting lists and to address other cost containment measures 
that State AIDS Drug Assistance Programs implement after January 1, 
2009. Amounts transferred under this section shall be used by States in 
a manner consistent with their State AIDS Drug Assistance Program.
    (b) Allocations.--In allocating funds transferred under subsection 
(a), the Secretary of Health and Human Services shall--
            (1) give special consideration to both the total scope, and 
        the basis, of a State's AIDS Drug Assistance Program needs, 
        including the total number of patients on a waiting list, 
        eligibility requirements, and other cost containment measures 
        implemented by a State's AIDS Drug Assistance Program; and
            (2) ensure that funds shall only be used to provide 
        treatments to individuals who were eligible to participate in 
        the State AIDS Drug Assistance Program on the date of enactment 
        of this Act.
                                 <all>
```
[Federal Register Volume 74, Number 110 (Wednesday, June 10, 2009)]
[Notices]
[Pages 27551-27552]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-13662]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Institute for Occupational Safety and Health; Decision 
To Evaluate a Petition To Designate a Class of Employees for the Norton 
Company in Worcester, MA, To Be Included in the Special Exposure Cohort

AGENCY: National Institute for Occupational Safety and Health (NIOSH), 
Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: HHS gives notice as required by 42 CFR 83.12(e) of a decision 
to evaluate a petition to designate a class of employees for the Norton 
Company in Worcester, Massachusetts, to be included in the Special 
Exposure Cohort under the Energy Employees Occupational Illness 
Compensation Program Act of 2000. The initial proposed definition for 
the class being evaluated, subject to revision as warranted by the 
evaluation, is as follows:
    Facility: Norton Company.
    Location: Worcester, Massachusetts.
    Job Titles and/or Job Duties: All Atomic Weapons Employer 
employees.
    Period of Employment: January 1, 1945 through December 31, 1957.

[[Page 27552]]


FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of 
Compensation Analysis and Support, National Institute for Occupational 
Safety and Health (NIOSH), 4676 Columbia Parkway, MS C-46, Cincinnati, 
OH 45226, Telephone 513-533-6800 (this is not a toll-free number). 
Information requests can also be submitted by e-mail to <a href="/cdn-cgi/l/email-protection#216e626072616265620f666e77"><span class="__cf_email__" data-cfemail="216e626072616265620f666e77">[email protected]</span></a>.

Christine M. Branche,
Acting Director, National Institute for Occupational Safety and Health.
[FR Doc. E9-13662 Filed 6-9-09; 8:45 am]
BILLING CODE 4163-19-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
##### 



Exhibit 10.1

First Amendment to Nextel Communications, Inc.
Change of Control Retention Bonus and
Severance Pay Plan (Effective September 19, 2002)

Section 3(g) of the Nextel Communications, Inc. Change of Control
Retention Bonus and Severance Pay Plan is hereby amended and restated in its
entirety to read as follows:



| |                                                                                                                                                                                                                                                    
| | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | (g) Employer means the Company, each of its wholly owned
subsidiaries, and any other subsidiary of the Company to which the
Plan has been extended by the Board (or by the Compensation
Committee of the Board) and which has adopted the Plan.
<PAGE>

                                                                    Exhibit 32.2

                                CERTIFICATION OF
                             CHIEF FINANCIAL OFFICER
                        OF MISSION RESOURCES CORPORATION

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, 18 U.S.C. Section 1350, and accompanies the annual report on Form 10-Q
(the "FORM 10-Q") for the quarter ended June 30, 2004 of Mission Resources
Corporation (the "ISSUER").

I, Richard W. Piacenti, the Chief Financial Officer of the Issuer, certify that:

      (i)   the Form 10-Q fully complies with the requirements of section 13(a)
            or section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C.
            78m(a) or 78o(d)); and

      (ii)  the information contained in the Form 10-Q fairly presents, in all
            material respects, the financial condition and results of operations
            of the Issuer.

      Dated: August 10, 2004                      /s/ Richard W. Piacenti
                                                  -----------------------

Subscribed and sworn to before me
this 10th day of August 2004

/s/ Carmen M. Garcia
--------------------

Notary Public in and for the
State of Texas

My commission expires: May 15, 2006

            A signed original of this written statement required by Section 906
            has been provided to Mission Resources Corporation and will be
            retained by Mission Resources Corporation and furnished to the
            Securities and Exchange Commission or its staff upon request.
MISCELLANEOUS DISMISSALS

96-2515.

#### State ex rel. Ochs v. Indus. Comm.

Franklin App. No. 95APD10-1359. This cause is pending before the court as a cross-appeal from the Court of Appeals for Franklin County. It appears from the records of this court that cross-appellant has not filed a brief, due March 31, 1997, in compliance with the Rules of Practice of the Supreme Court and therefore has failed to prosecute this cause with the requisite diligence. Upon consideration thereof,

IT IS ORDERED by the court that this cause be, and hereby is, dismissed *sua sponte.*